Eye Disease
Singapore wants healthcare AI that does not think like the West. Cardiometabolic care is its first real test
Singapore’s publicly funded SIMFONI programme will adapt foundation AI models using local clinical data, guidelines and workflows, beginning with cardiometabolic decision support in primary care and multimodal tools for eye disease. Localisation could make healthcare AI safer and more relevant. It could also automate local blind spots unless subgroup performance, accountability and clinical impact are…
El Salvador Eliminated Trachoma. The Certificate Is Not The Finish Line.
The Most Preventable Cause of Vision Loss May Still Be Smoking
Cellular Reprogramming Enters Neuro-Ophthalmology
Not All Eye Infections Are Equal: New Evidence Points to a Precision Medicine Approach
The Air We Breathe May Be Shaping the Future Burden of Blindness
Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks
Diabetic Eye Screening Is Becoming Risk-Based
Abu Dhabi Puts Rare Eye Gene Therapy on the Regional Map
AI Eye Screening Has an Image Quality Problem
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.